Stay updated on Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added a Locations section showing Houston, Texas as a study site. The update also updates the revision from v3.3.2 to v3.3.3 and removes the old 'Texas Locations' header as well as the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T22:22:30.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision label updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T11:37:32.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Removal of the government funding delay banner from the page; this does not affect the study details or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:14:45.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Administrative updates to the study record, including a newer last update date and results posting information, with no changes to the study design or eligibility criteria.
    Difference
    0.4%
    Check dated 2025-11-03T21:14:53.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.
    Difference
    2%
    Check dated 2025-10-06T05:38:18.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Page version updated from v3.0.2 to v3.1.0; removal of the term 'Liver Cancer'.
    Difference
    1.0%
    Check dated 2025-09-29T03:07:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Elbasvir/Grazoprevir Clinical Trial page.